Venous or arterial samples for activated clotting time measurements: a systematic review

被引:1
|
作者
Iddawela, Sashini [1 ]
Swamy, Priti [2 ]
Member, Sajid [3 ]
Harky, Amer [4 ,5 ,6 ,7 ,8 ]
机构
[1] Univ Hosp Birmingham, Dept Resp Med, Birmingham, W Midlands, England
[2] Kings Coll London, GKT Sch Med Educ, London, England
[3] Univ Cent Lancashire, Lancashire Sch Med & Dent, Greenbank Bldg, Preston, Lancs, England
[4] Liverpool Heart & Chest Hosp, Dept Cardiothorac Surg, Thomas Dr, Liverpool L14 3PE, Merseyside, England
[5] Univ Liverpool, Fac Hlth & Iife Sci, Dept Integrat Biol, Liverpool, Merseyside, England
[6] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[7] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[8] Alder Hey Children Hosp, Dept Cardiac Surg, Liverpool, Merseyside, England
来源
PERFUSION-UK | 2021年 / 36卷 / 08期
关键词
clotting factors; ACT; venous; arterial; cardiac surgery; cardiac catheterisation; COAGULATION TIME; HEPARIN; THROMBOELASTOGRAPHY; SURGERY;
D O I
10.1177/0267659120967836
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The systematic review aims to investigate the effect of sampling source on activated clotting time (ACT) measurement within cardiovascular surgery and cardiac catheterisation. It also examines the evidence surrounding novel clot assessment techniques and associated sampling variation. Methods: A comprehensive electronic search was conducted using PubMed, MEDLINE, Scopus, Cochrane database, and Google Scholar until 20th June 2020. All studies reporting sampling source variability of ACT in cardiac surgery, vascular surgery and cardiac catheterisation were included. Results: Fourteen studies were included in the systematic review. Inconsistent reports of variability were seen in cardiac surgery and cardiac catheterisation. There were no studies directly examining ACT variability in vascular surgery. Novel clot assessment techniques have been validated in cardiac surgery, but measurements vary depending on sampling source. Conclusion: Sampling source should be kept consistent to facilitate effective haemostatic strategies. More research is needed regarding variability in vascular surgery and novel clot assessment techniques.
引用
收藏
页码:845 / 852
页数:8
相关论文
共 50 条
  • [41] ACTIVATED CLOTTING TIME VERSUS ACTIVATED PARTIAL THROMBOPLASTIN TIME FOR THERAPEUTIC MONITORING OF HEPARIN
    SIMKO, RJ
    TSUNG, FFW
    STANEK, EJ
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (10) : 1015 - 1021
  • [42] Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration
    Koerber, JM
    Smythe, MA
    Begle, RL
    Mattson, JC
    Kershaw, BP
    Westley, SJ
    PHARMACOTHERAPY, 1999, 19 (08): : 922 - 931
  • [43] Inadvertent Arterial Placement of Central Venous Catheters: Systematic Review and Guidelines for Treatment
    Dornbos, David L., III
    Nimjee, Shahid M.
    Smith, Tony P.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 30 (11) : 1785 - 1794
  • [44] A systematic review of management of inadvertent arterial injury during central venous catheterisation
    Dixon, Oliver G. B.
    Smith, George E.
    Carradice, Daniel
    Chetter, Ian C.
    JOURNAL OF VASCULAR ACCESS, 2017, 18 (02): : 97 - 102
  • [45] Lower limb venous and arterial peripheral diseases and work conditions: systematic review
    Huo Yung Kai, Samantha
    Ferrieres, Jean
    Carles, Camille
    Turpin, Marion
    Lapebie, Francois-Xavier
    Dutheil, Frederic
    Bura-Riviere, Alessandra
    Esquirol, Yolande
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2021, 78 (01) : 4 - 14
  • [46] Correlation between activated clotting time and activated partial thromboplastin times
    Smythe, MA
    Koerber, JM
    Nowak, SN
    Mattson, JC
    Begle, RL
    Westley, SJ
    Balasubramaniam, M
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (01) : 7 - 11
  • [47] Point-of-care ecarin clotting time versus activated clotting time in correlation with bivalirudin concentration
    Casserly, IP
    Kereiakes, DJ
    Gray, WA
    Gibson, PH
    Lauer, MA
    Reginelli, JP
    Moliterno, DJ
    THROMBOSIS RESEARCH, 2004, 113 (02) : 115 - 121
  • [48] Correlation of point-of-care ecarin clotting time versus activated clotting time with Bivalirudin concentrations
    Cho, L
    Kottke-Marchant, K
    Lincoff, AM
    Roffi, M
    Reginelli, JP
    Kaldus, T
    Moliterno, DJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (09): : 1110 - 1113
  • [49] Comparison of the i-STAT handheld activated clotting time with the hemochron activated clotting time during and after percutaneous coronary intervention
    Schussler, JM
    Aguanno, JJ
    Glover, EN
    Vish, NA
    Wissinger, LA
    Schumacher, JR
    Wheelan, KR
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (04): : 464 - +
  • [50] BEDSIDE WHOLE-BLOOD APTT BUT NOT ACTIVATED CLOTTING TIME PREDICTS BLEEDING POST ARTERIAL SHEATH REMOVAL
    CARTER, AJ
    BLUMENTHAL, RS
    RESAR, JR
    COOMBS, VJ
    GLOTH, ST
    DALAL, JN
    BRINKER, JA
    CIRCULATION, 1994, 90 (04) : 621 - 621